BTIG Reiterates Buy on CeriBell, Maintains $30 Price Target

Benzinga Newsdesk www.benzinga.com Neutral 84.8%

Neg 0% Neu 84.8% Pos 0%

BTIG analyst Marie Thibault reiterates CeriBell (NASDAQ:CBLL) with a Buy and maintains $30 price target.

Comments

No comments yet. Be the first!